CLINICAL TRIAL SUMMARY

MDACC Study No:2013-0479(2005-0813CML) (clinicaltrials.gov NCT No: NCT01903733)
Title:An Open-Label Bosutinib Treatment Extension Study for Subjects with Chronic Myeloid Leukemia (CML) Who Have Previously Participated in Bosutinib Studies B1871006 or B1871008
Principal Investigator:Jorge Cortes
Treatment Agent:Bosutinib
Study Status:Open
Study Description:The goal of this clinical research study is to learn about the long-term side
effects of Bosulif (bosutinib) after you discontinue therapy.

Hide details for General InformationGeneral Information

Disease Group:Leukemia
Phase of Study:N/A
Treatment Agents:Bosutinib
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:Pfizer
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Jorge Cortes
Dept:Leukemia
For Clinical Trial Enrollment:713-794-5783
For General Questions about Clinical Trials:1-877-MDA-6789


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults